featured
Bococizumab Reduces Cardiovascular Events in High-Risk Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
N. Engl. J. Med 2017 Mar 17;[EPub Ahead of Print], PM Ridker, J Revkin, P Amarenco, R Brunell, M Curto, F Civeira, M Flather, RJ Glynn, J Gregoire, JW Jukema, Y Karpov, JJ Kastelein, W Koenig, A Lorenzatti, P Manga, U Masiukiewicz, M Miller, A Mosterd, J Murin, JC Nicolau, S Nissen, P Ponikowski, RD Santos, PF Schwartz, H Soran, H White, RS Wright, M Vrablik, C Yunis, CL Shear, JC TardifFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.